Dr. Jung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2417 TENOR LN
Alpharetta, GA 30009Phone+1 470-641-8948
Summary
- I’m an interventional and diagnostic radiologist having Korean MD license and US permanent resident VISA. I am serving as an Associate Scientist focusing on PAD research at Emory University. I have passed Step 1 and am currently actively working on Step 2. I'm interested in pursuing a career in interventional radiology in the United States. I have eighteen years of medical experience including six years in interventional radiology and nine years in diagnostic radiology. Recently, I’ve worked as an assistant professor at CHA Bundang Medical Center, CHA University, College of Medicine
Education & Training
- Yonsei UniversityClass of 2005
Publications & Presentations
Journal Articles
- Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular CarcinomaYS SongHN Yang, BD Kang, JK Cheon, IH Kim, HY Kim, WS Lee, YB Sang, SH Jung, HY Lim, VE Gaillard, C Kim, HJ Chon, Liver Cancer, 5/25/2023
- High serum IL-6 correlated with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinomaHN Yang, BD Kang, YJ Ha, SH Lee, IH Kim, HY Kim, WS Lee, GI Kim, SH Jung, SY Rha, VE Gaillard, JK Cheon, C Kim, HJ Chon, JHEP Reports, 1/16/2023
- Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular CarcinomaC Kim, HN Yang, IH Kim, BD Kang, HY Kim, HH Kim, WS Lee, SH Jung, HY Lim, JK Cheon, HJ Chon, JAMA Oncol, 10/20/2022
- Join now to see all
Research History
- Assistant ScientistLarge animal study for cell therapy of peripheral arterial disease with molecular imaging and interventional radiology2023 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: